Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 In vitro and in vivo antimalarial activities of a non-glycosidic 18-membered macrolide antibiotic, borrelidin, against drug-resistant strains of Plasmodia.

Literature DB >> 14563165

In vitro and in vivo antimalarial activities of a non-glycosidic 18-membered macrolide antibiotic, borrelidin, against drug-resistant strains of Plasmodia.

Kazuhiko Otoguro, Hideaki Ui, Aki Ishiyama, Miyuki Kobayashi, Hideaki Togashi, Yoko Takahashi, Rokuro Masuma, Haruo Tanaka, Hiroshi Tomoda, Haruki Yamada, Satoshi Omura.

Abstract

Entities: Chemical

Mesh：

Substances：

Year: 2003 PMID： 14563165 DOI： 10.7164/antibiotics.56.727

Source DB: PubMed Journal: J Antibiot (Tokyo) ISSN： 0021-8820 Impact factor: 2.649

Keyword Cloud
Cited

× No keyword cloud information.

18 in total

Review 1. Prospects for aminoacyl-tRNA synthetase inhibitors as new antimicrobial agents.

Authors: Julian Gregston Hurdle; Alexander John O'Neill; Ian Chopra
Journal: Antimicrob Agents Chemother Date: 2005-12 Impact factor: 5.191

2. Antimalarial Benzoxaboroles Target Plasmodium falciparum Leucyl-tRNA Synthetase.

Authors: Ebere Sonoiki; Andres Palencia; Denghui Guo; Vida Ahyong; Chen Dong; Xianfeng Li; Vincent S Hernandez; Yong-Kang Zhang; Wai Choi; Jiri Gut; Jennifer Legac; Roland Cooper; M R K Alley; Yvonne R Freund; Joseph DeRisi; Stephen Cusack; Philip J Rosenthal
Journal: Antimicrob Agents Chemother Date: 2016-07-22 Impact factor: 5.191

Review 3. Progress and challenges in aminoacyl-tRNA synthetase-based therapeutics.

Authors: Christopher S Francklyn; Patrick Mullen
Journal: J Biol Chem Date: 2019-01-22 Impact factor: 5.157

4. Liposomal borrelidin for treatment of metastatic breast cancer.

Authors: Moonkyoung Jeong; Heegon Kim; Sunghoon Kim; Ji-Ho Park
Journal: Drug Deliv Transl Res Date: 2018-10 Impact factor: 4.617

5. The growing pipeline of natural aminoacyl-tRNA synthetase inhibitors for malaria treatment.

Authors: Adélaïde Saint-Léger; Christopher Sinadinos; Lluís Ribas de Pouplana
Journal: Bioengineered Date: 2016-03-10 Impact factor: 3.269

6. Analogs of natural aminoacyl-tRNA synthetase inhibitors clear malaria in vivo.

Authors: Eva Maria Novoa; Noelia Camacho; Anna Tor; Barrie Wilkinson; Steven Moss; Patricia Marín-García; Isabel G Azcárate; José M Bautista; Adam C Mirando; Christopher S Francklyn; Sònia Varon; Miriam Royo; Alfred Cortés; Lluís Ribas de Pouplana
Journal: Proc Natl Acad Sci U S A Date: 2014-12-08 Impact factor: 11.205

In vitro and in vivo antimalarial activities of a non-glycosidic 18-membered macrolide antibiotic, borrelidin, against drug-resistant strains of Plasmodia.

Review 1. Prospects for aminoacyl-tRNA synthetase inhibitors as new antimicrobial agents.

2. Antimalarial Benzoxaboroles Target Plasmodium falciparum Leucyl-tRNA Synthetase.

Review 3. Progress and challenges in aminoacyl-tRNA synthetase-based therapeutics.

4. Liposomal borrelidin for treatment of metastatic breast cancer.

5. The growing pipeline of natural aminoacyl-tRNA synthetase inhibitors for malaria treatment.

6. Analogs of natural aminoacyl-tRNA synthetase inhibitors clear malaria in vivo.

7. Insights into the preclinical treatment of blood-stage malaria by the antibiotic borrelidin.

8. Inhibition of Plasmodium falciparum Lysyl-tRNA synthetase via an anaplastic lymphoma kinase inhibitor.

Review 9. Aminoacyl-tRNA synthetases as drug targets in eukaryotic parasites.

10. Synthesis of complex intermediates for the study of a dehydratase from borrelidin biosynthesis.